Oncology Experts Update Cancer Treatment Pathways

Physicians are refining clinical guidelines to better manage the rapid introduction of new cancer therapies.

Updated on Oct. 21, 2026 in Cancer

Oncology Experts Update Cancer Treatment Pathways

Live Poll

Do you believe automated data systems will improve the standard of cancer care for patients?

At the September 2026 PCOC conference in Nashville, OneOncology physician Edward Arrowsmith outlined how cancer treatment pathways are currently being updated to track new drug availability. These pathways serve as essential clinical guides for practitioners managing complex oncology care.

Why it matters

Updating treatment protocols is critical to keep pace with the accelerating number of newly approved cancer therapies. This ensures that clinical decisions align with the latest medical advancements and drug indications.

Current pathways rely on quarterly disease group reviews and emergency email meetings to integrate new indications. Full implementation of automated real-time data feeds into these pathways is projected to occur within 5 years.

The players

Edward Arrowsmith

He is a physician at OneOncology who presented on the evolution of clinical pathways at the PCOC 2026 conference.

OneOncology

This organization supports community oncology practices by providing tools and resources for cancer care management.

The details

OneOncology currently manages these pathways as static documents that undergo periodic updates throughout the year. The process involves disease-specific groups convening via email to formally incorporate new commercial drug indications into the treatment framework.

September 24-25, 2026: PCOC 2026 conference held in Nashville, Tennessee.
Within 5 years: Expected timeline for the implementation of real-time data integration.

The Big Picture

This effort aligns with the PCOC 2026 conference research agenda, which emphasizes the modernization of clinical oncology workflows. The transition toward real-time automated data is seen as the next necessary evolution in managing complex treatment regimens.

Integrating new therapies faster means patients may gain quicker access to the most recent evidence-based treatment options. Future updates incorporating genomic data will further tailor these pathways to individual patient needs.

The takeaway

The move toward dynamic, real-time pathway updates reflects the industry's attempt to manage the rapid influx of new oncological drugs. Practitioners should prepare for future systems that incorporate genomic data and patient-reported outcomes directly into their clinical decision-making process.